PubMed Health⌕ Search

PubMed · 10719717

[Do physicians interpret therapy outcome differently than students?].

Abstract

Results are presented in the most varied ways in medical publications and advertising material. The reader should be able to interpret the results of such studies accurately. In the present investigation our interest focused on whether a physician learns to analyse results correctly in medical school or in his subsequent clinical career. We also investigated whether the interpretation of therapeutic data differs as between students in the 4th year of medical school, students of the 6th year and physicians. In a questionnaire, one result from the Helsinki Heart Study was presented in for different ways: (a) absolute risk reduction, (b) relative risk reduction, (c) NNT (number needed to treat) and (d) percentage of patients without a cardiovascular event during the monitoring period. To each group we assigned a different drug. We interviewed students in the 4th and 6th years of medical school, physicians during a continuing education course and physicians before and after an evidence-based medicine (EBM) course. They replied by stating which drug they would select for therapy. Evaluation of the questionnaire showed that the majority regarded the drug for relative risk reduction as the most effective. Physicians taking part in the EBM course analysed the statistical data better than the other groups interviewed, and their answers even improved significantly after the EBM course. There was no difference in the interpretation of therapeutic results between students and physicians who had not taken part in an EBM course. The study also found that in all the groups interviewed the presentation of the results of scientific studies has a marked influence on their interpretation. We conclude that interpretation of medical studies should form part of every student's and physicians's training, either in medical school or continuing education courses. On the other hand, the results of studies should be uniformly expressed in absolute figures, to make it easier to compare different results.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Damur, J Steurer. 2000-02-12. [Do physicians interpret therapy outcome differently than students?].. https://pubmed.ncbi.nlm.nih.gov/10719717/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris.

OBJECTIVE: Ischemic preconditioning is an increased tolerance to myocardial ischemia during the second of two consecutive exercise tests. ATP-sensitive K(+) channel blockers, such as glinides and sulfonylurea drugs, can induce loss of ischemic preconditioning. This study aimed to investigate the effects of repaglinide, a hypoglycemic agent with an affinity for myocardial ATP-sensitive K (+)channels, on the results of consecutive exercise tests in patients with diabetes and multivessel coronary artery disease. METHODS: Forty-two patients with type 2 diabetes and chronic stable angina pectoris, and two-vessel or three-vessel disease participated in this study. The patients underwent two consecutive treadmill exercise tests (phase 1). On the day after these exercise tests, 2 mg of oral repaglinide was given to the patients. One week later, two exercise tests were repeated consecutively (phase 2). RESULTS: All patients achieved 1.0-mm ST-segment depression during the four exercise tests (T1, T2, T3, and T4). In phase 2, seven patients improved in time to onset of 1.0-mm ST-segment depression. The worsening of the time to onset of 1.0-mm ST-segment depression in phase 2 demonstrated ischemic preconditioning block in 83.3% of patients (P=0.0001). Even the postexercise electrocardiographic parameters (ST-segment depression morphology and magnitude and arrhythmias) were significantly different between the groups with and without pharmacologic ischemic preconditioning block (P=0.031). CONCLUSIONS: Repaglinide, an oral hypoglycemic agent with ATP-sensitive K(+) channel-blocker activity, eliminated the myocardial ischemic preconditioning in patients with coronary disease and diabetes.

Angina Pectoris↗